What is Personalized Medical Care-?
Personalized Medical care guarantees that they will have a committed physician who will provide patients competent medical care while also being compassionate. Personalized Medical care is an overall framework for treatment that brings together predictive technologies and an involved patient to coordinate care with the primary goal of improving health and preventing disease. Personalized health planning shared decision-making, and patient engagement is all aspects of Personalized Medical care. It aims to reduce chronic-care spending by encouraging healthy habits and planning.
|Unit||Value (USD Million)|
|Key Companies Profiled||Accolade Inc. (United States), Quartz Bio S.A (Switzerland), American Well (United States), MDLIVE Inc. (United States), Teladoc Health Inc. (United States), Doctor on demand Inc (United States), MeMD (United States), Encounter Telehealth (United States), Global Med (United States) and SnapMD (United States)|
The market study is broken down and major geographies with country level break-up.
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analysts at AMA Research estimates that Players from United States will contribute to the maximum growth of Global Personalized Medical Care- market throughout the predicted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Accolade Inc. (United States), Quartz Bio S.A (Switzerland), American Well (United States), MDLIVE Inc. (United States), Teladoc Health Inc. (United States), Doctor on demand Inc (United States), MeMD (United States), Encounter Telehealth (United States), Global Med (United States) and SnapMD (United States) are some of the key players that are part of study coverage.
AdvanceMarketAnalytics has segmented the market of Global Personalized Medical Care- market by Type, Application and Region.
On the basis of geography, the market of Personalized Medical Care- has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Services, the sub-segment i.e. Virtual primary care will boost the Personalized Medical Care- market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End-users, the sub-segment i.e. Hospitals will boost the Personalized Medical Care- market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
In September 2021 - Accolade, Inc. the company that provides millions of people and their families with exceptional healthcare, announce the launch of Personalized Healthcare, a new category that enables a nationally scalable model of value-based care to meet the quadruple aim.
- Increasing investment in the research and development
- Significant reduction in healthcare cost burden to boost demand
- The largest increase in telemedicine visits during the COVID-19
- The rise in the chronic disease
- Increasing the spending on the healthcare
- High cost of the personalized medical care services
- Lack of awareness in the developing countries
Key Target AudienceGovernment research institutes, Academic institutes and universities, Venture capitalists, Government regularity bodies, Private research organization and Others
About ApproachTo evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand companys positioning regarding market value, volume and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.
Frequently Asked Questions (FAQ):
1. What all players are profiled in the study?
The standard version of the report profiles players such as Accolade Inc. (United States), Quartz Bio S.A (Switzerland), American Well (United States), MDLIVE Inc. (United States), Teladoc Health Inc. (United States), Doctor on demand Inc (United States), MeMD (United States), Encounter Telehealth (United States), Global Med (United States) and SnapMD (United States) etc.
2. Can we have customized study for Personalized Medical Care- Market?
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
3. What would be the Market Size of Personalized Medical Care- Market by 2027?
Analysts at AMA estimates Personalized Medical Care- Market to reach USD Million by 2027.